Search Results - "Sandén, Carl"
-
1
-
2
IL1RAP antibodies block IL-1–induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
Published in Blood (08-12-2016)“…Chronic myeloid leukemia (CML) is currently treated with tyrosine kinase inhibitors, but these do not effectively eliminate the CML stem cells. As a…”
Get full text
Journal Article -
3
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
Published in Proceedings of the National Academy of Sciences - PNAS (25-08-2015)“…Acute myeloid leukemia (AML) is associated with a poor survival rate, and there is an urgent need for novel and more efficient therapies, ideally targeting AML…”
Get full text
Journal Article -
4
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
Published in Haematologica (Roma) (01-09-2022)Get full text
Journal Article -
5
Clonal competition within complex evolutionary hierarchies shapes AML over time
Published in Nature communications (05-02-2020)“…Clonal heterogeneity and evolution has major implications for disease progression and relapse in acute myeloid leukemia (AML). To model clonal dynamics in…”
Get full text
Journal Article -
6
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases
Published in Blood (26-09-2024)“…•Single-cell multiomics delineates the maturation block in childhood ALL with DUX4-r cases exhibiting a high degree of lineage infidelity.•DUX4-r ALL displays…”
Get full text
Journal Article -
7
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
Published in Haematologica (Roma) (01-08-2020)“…Aberrantly expressed cytokines in the bone marrow (BM) niche are increasingly recognized as critical mediators of survival and expansion of leukemic stem…”
Get full text
Journal Article -
8
Combinatorial molecule screening identified a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells
Published in Haematologica (Roma) (01-10-2021)“…Combination treatment has proven effective for patients with acute promyelocytic leukemia, exemplifying the importance of therapy targeting multiple components…”
Get full text
Journal Article -
9
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
Published in BMC cancer (27-09-2013)“…The t(6;9)(p23;q34) chromosomal translocation is found in 1% of acute myeloid leukemia and encodes the fusion protein DEK-NUP214 (formerly DEK-CAN) with…”
Get full text
Journal Article -
10
Transcriptional profiling demonstrates altered characteristics of CD8+ cytotoxic T‐cells and regulatory T‐cells in TP53‐mutated acute myeloid leukemia
Published in Cancer medicine (Malden, MA) (01-08-2022)“…Background Acute myeloid leukemia (AML) patients have limited effect from T‐cell‐based therapies, such as PD‐1 and CTLA‐4 blockade. However, recent data…”
Get full text
Journal Article -
11
Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells
Published in Haematologica (Roma) (01-02-2017)“…The zinc finger transcription factor Wilms tumor gene 1 (WT1) acts as an oncogene in acute myeloid leukemia. A naturally occurring alternative splice event…”
Get full text
Journal Article -
12
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
Published in Haematologica (Roma) (01-03-2018)“…Tyrosine kinase inhibitors (TKIs) are highly effective for the treatment of chronic myeloid leukemia (CML), but very few patients are cured. The major…”
Get full text
Journal Article -
13
The DEK oncoprotein is upregulated by multiple leukemia-associated fusion genes
Published in Blood cells, molecules, & diseases (01-03-2015)Get full text
Journal Article -
14
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
Published in Blood advances (11-04-2023)“…•C3AR is selectively expressed on NPM1-mutated primary AML cells compared to both NPM1 wild type cases and normal hematopoietic stem cells.•The C3a/C3AR…”
Get full text
Journal Article -
15
The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation
Published in Molecular cancer (12-09-2014)“…The DEK gene is highly expressed in a wide range of cancer cells, and a recurrent translocation partner in acute myeloid leukemia. While DEK has been…”
Get full text
Journal Article -
16
The p53 target gene TRIM22 directly or indirectly interacts with the translation initiation factor eIF4E and inhibits the binding of eIF4E to eIF4G
Published in Biology of the cell (01-08-2012)“…Background information The interferon (IFN)‐inducible protein TRIM22 (Staf50) is a member of the tripartite motif protein family and has been suggested a role…”
Get full text
Journal Article -
17
The DEK oncoprotein and its emerging roles in gene regulation
Published in Leukemia (01-08-2015)“…The DEK oncogene is highly expressed in cells from most human tissues and overexpressed in a large and growing number of cancers. It also fuses with the NUP214…”
Get full text
Journal Article -
18
-
19
Single-Cell Genomics Details the Maturation Block in BCP-ALL and Identifies Therapeutic Vulnerabilities in DUX4-Rearranged Cases
Published in Blood (02-11-2023)“…B cell progenitor acute lymphoblastic leukemia (BCP-ALL) is the most common childhood malignancy. It is initiated by multiple genetic alterations, causing a…”
Get full text
Journal Article -
20
Combinatorial molecule screening identifies a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells
Published in Haematologica (Roma) (2021)“…Combination treatment has proven effective for patients with acute promyelocytic leukemia, exemplifying the importance of therapy targeting multiple components…”
Get full text
Journal Article